Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, is able to detect regions of damage and other disease-related features while using 60% less gadolinium — a chemical ...
It enables the discovery of macro- and microstructural tissue ... imaging data. MRI acquisition protocols like T1-weighted or T2-weighted imaging can produce rich anatomical contrast and produce ...